North America is a leading region for oral vaccines, supported by strong vaccine research and development, a well-established regulatory framework and high public health spending. The US market is anchored by products such as the oral typhoid vaccine Vivotif, the rotavirus vaccines RotaTeq (Merck) and Rotarix (GSK), and the adenovirus vaccine used by the US military, while cholera vaccine...